Background Benefits of phosphate-lowering interventions on clinical outcomes in patients
with CKD are unclear; systematic reviews have predominantly involved patients on dialysis …

Background Chronic kidney disease-mineral and bone disorder (CKD-MBD), a complication
of chronic kidney disease, has been linked to reduced quality and length of life. High serum …

BACKGROUND: Phosphate binders are widely used to control serum phosphorus levels in
patients with chronic kidney disease (CKD). We analyzed the effects of phosphate binders …

Background Guidelines preferentially recommend noncalcium phosphate binders in adults
with chronic kidney disease (CKD). We compare and rank phosphate-binder strategies for …

Phosphate binders are among the most common medications prescribed to patients with
kidney failure receiving dialysis and are often used in advanced chronic kidney disease …

Background Chronic kidney disease-mineral and bone disorder (CKD-MBD) has been
linked to poor health outcomes, including diminished quality and length of life. This condition …

Convincing epidemiological data have repeatedly shown that increased phosphate levels
as well as generous phosphate intakes are associated with unfavourable outcome both in …

Phosphate binders are prescribed to chronic kidney disease (CKD) patients based on
associations of serum phosphate concentrations with mortality and calcification …

Phosphate levels are strikingly associated with poor outcomes in chronic kidney disease
(CKD) and endstage renal disease (ESRD) patients. Numerous epidemiological studies …

Background Besides reducing hyperphosphatemia in chronic kidney disease (CKD)
patients, phosphate lowering agents might provide beneficial effects on clinical and …